Currently Viewing:
Cost-Sharing Roundtable — The Patient Assistance Safety Net: How Many Need Help? How Many Are Helped?
Addressing Financial Concerns at the Outset to Improve Patient Outcomes
March 02, 2018
Financial Burden an Unintended Outcome of Cancer Care
March 02, 2018
Michele McCourt Discusses Growing Financial Hardships for Patients With Cancer
March 03, 2018
M. Kristina Wharton on the Role of Federally Qualified Health Centers
March 04, 2018
Where Does the Existing Healthcare Safety Net Fall Short?
March 05, 2018
Cost-Sharing Roundtable—Introduction
March 05, 2018
Patient Education Vital for Improved Medicare Access, Say Panelists
March 06, 2018
Policy Improvement Areas to Reduce Financial Hardship
March 07, 2018
Dr Todd Yezefski Discusses Using Financial Navigator Programs
March 08, 2018
Ed Haislmaier on Policy Changes That Impact Healthcare Financial Burdens
March 09, 2018
Leigh Purvis Discusses the Burden of High Prescription Drug Costs
March 14, 2018
Ed Haislmaier: Impact of Business Coalitions on Healthcare Costs
March 23, 2018
Currently Reading
Dan Klein on Lack of Cost Sharing in Medicare, Drugs Coming Down the Pipeline
March 27, 2018
Kristina Wharton Analyzes the Health of the Population Using FQHCs
March 29, 2018
Dr Todd Yezefski Discusses the Financial Hardships of Cancer Treatment
March 30, 2018
Leigh Purvis on Out-of-Pocket Costs for Medicare Beneficiaries
March 31, 2018
Ed Haislmaier: Medicare Is "Stuck in a Time Warp"
April 04, 2018
Dan Klein Outlines Policy Changes to Strengthen the Safety Net
April 05, 2018
Kristina Wharton Discusses Services Provided at Federally Qualified Health Centers
April 09, 2018
Dr Todd Yezefski on the Benefits of Financial Navigators in Oncology
April 14, 2018
Ed Haislmaier on Efforts to Lower Drug Costs
April 15, 2018
Michele McCourt on Potential New Therapies for Patients With Cancer
April 17, 2018
Leigh Purvis Outlines the Burdens of High Drug Costs on Medicare Beneficiaries
April 20, 2018
Dan Klein Explains the Need for Patient Assistance Foundations
April 22, 2018

Dan Klein on Lack of Cost Sharing in Medicare, Drugs Coming Down the Pipeline

Dan Klein, President and CEO, Patient Access Network Foundation, discusses how the lack of a limit on cost sharing in Medicare affects patient outcomes and disease states that PAN Foundation is keeping an eye on.
 


Dan Klein, President and CEO, Patient Access Network Foundation, discusses how the lack of a limit on cost sharing in Medicare affects patient outcomes and disease states that PAN Foundation is keeping an eye on.

Transcript

How does the lack of a limit on cost sharing in Medicare affect patient outcomes?

Patient outcomes are really complicated as far as the various factors that affect success with therapy. Obviously out-of-pocket costs are a well-known barrier to initiating treatment and to being adherent to treatment. So, we feel that we are able to address that successfully for many patients by giving them a grant that covers their out-of-pocket costs. But, it’s not a guarantee, so what we try to do is connect patients with other support services. We have a very active alliance partner program that patients can opt into, and if they need social support or peer support or help with other challenges they’re facing because of their illness, they can often get that from 1 of our patient advocacy partners.

Are there any disease states that PAN Foundation is keeping an eye on the drugs coming down the pipeline?

We’ve looked at a number of different diseases, and every year we have opened between 6 and 8 new disease funds, new indications that we provide assistance for. Some of the ones that we look at that are what we call prospective, we publish on our website so that potential donors can see them. One area that I know we’re interested in, that we’re taking a look at now, is amyloidosis. It’s a potentially large area; it’s a little different than the typical disease area. It’s got a lot of challenges in terms of different symptoms, and we may be able to put a fund in place for that this coming year.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up